Artificial Pancreas Market
“The global artificial pancreatic market size is estimated to reach a CAGR of 11% during the forecast period (2024-2031).” According to Datam Intelligence Research Report
Market growth opportunities (2025-2031):
The artificial pancreas market is set to grow significantly until 2031, driven by an increase in the global prevalence of diabetes and an increase in demand for automated glycemic control. Technological advances in sensors, insulin pumps, and AI-powered algorithms have driven innovation and reliability in closed-loop systems. The improved patient comfort and accuracy also attracts wider clinical acceptance. The shift towards hybrid and fully automated systems opens up new commercial segments. Furthermore, emerging markets are expected to make a significant contribution as healthcare infrastructure and awareness grow.
Download the exclusive sample report now: (corporate email will get priority access): https://www.datamintelligence.com/download-sample/artificial-pancreas-market? sp
Artificial Pancreas Market: Recent Industry Development
March 2025: Researchers have issued a reinforcement learning optimized fuzzy controller (Takagi-Shugeno model), improving adaptability to dietary variability, stabilizing glucose in a simulation environment, and suggesting future enhancements in the AP algorithm.
January-July 2025: While FDA Clearance (June 2024) was in front of the window, in 2025, Omnipod 5 expanded its support for Dexcom G7 CGM and the support for the Omnipod app on iPhone, increasing accessibility and user control for both T1D and T2D users as T1D and T2D users that stabilized the smartphone ecosystem.
2025: Zealand Pharma has launched phase testing of stable glucagon analogs (Dasiglucagon) integrated into the betabionics dual hormone ILET bionic pancreatic system. This is the fourth phase II trial of the year, designed to test the safety and efficacy of adults with type 1 diabetes. Clinical results are expected in the first quarter of 2026.
Artificial Pancreas Market: Market Driver
The growth of diabetes cases around the world is accelerating the need for smart, automated insulin delivery solutions. Regulatory approvals for next-generation devices such as hybrid closed-loop systems have boosted market confidence. Technology integration of AI and real-time data improves treatment accuracy and safety. Increased adoption of favorable reimbursement policies and healthcare spending support in developed regions. Patients are increasingly fond of user-friendly systems that minimize the risk of hypoglycemia and reduce the burden of self-management.
Strategic players moving forward in the artificial pancreas market:
medtronic plc
✦Johnson & Johnson
Tandem Diabetes Care, Inc.
pancreum, Inc.
bigfoot Biomedical, Inc.
dexcom, Inc.
beta Bionics, Inc.
✦AdmetsysCorp.
✦Insulet Corporation
defimed
Get customizations in the report according to your requirements. https://www.datamintelligence.com/customize/artificial-pancreas-market? sp
Segments covered in the Artificial Pancreas Market:
by type: Threshold suspension device system, non-threshold suspension device system, control to range system, control to target system
Why buy the Artificial Pancreas Market report? :
➠Technology and Innovation: Track clinical trials and upcoming drug advancements to advance product development.
Corking Market Positioning and Competitive Strategy: Analyze product performance, market share and competitor tactics for strategic decision-making.
➠Practical evidence and physician insights: incorporate patient data and physician behavior to tailor products to your actual medical needs.
➠Price and Market Access: Review Refund Trends and Access Models optimize product pricing and launch strategies.
regulatulaturaly & Industry Shifts: covers policy changes, health system dynamics, and technology trends that affect market opportunities.
➠ Regional Growth and Expansion: Identify high-growth markets and investment opportunities for geographical expansion.
Regional Analysis of the Artificial Pancreas Market:
North America leads the global artificial pancreas market with its powerful research ecosystem, high diabetes burden and early adoption of innovative technologies. Europe is ranked as the second largest market with a strong refund framework and established healthcare systems. The Asia-Pacific region is the fastest growing region due to increased prevalence of diabetes, increased health investments, and increased demand for automated disease management solutions.
Conclusion:
The artificial pancreas market is evolving rapidly, with breakthroughs in automation and digital health conversion diabetes care. Market adoption is expected to accelerate across the region as devices become more intelligent and patient-centric. While North America and Europe continue to lead, the Asia-Pacific region has great potential for future growth. A strategic focus on innovation, affordability and access is key to exploiting global opportunities.
Buy now and unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now–page?report= artificial-pansreas-market? sp
Request a 2-day free trial access:
https://www.datamintelligence.com/reports-subscription? sp
Competitive competitive landscape
✅ Technology Roadmap Analysis
✅Sustainability Impact Analysis
Kol/Stakeholder Insights
✅Consumer behavior and demand analysis
cortimemport-export data monitoring
Rive Live Market & Pricing Trends
Please see the subscription dashboard.
https://www.youtube.com/watch?v=x5oeiqeqtwg
inquiry –
Company name: Datam Intelligence
Contact: Sai Kiran
Email: sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us –
Datam Intelligence is a market research and consulting company that provides end-to-end business solutions for organizations ranging from research to consulting. With Datam Intelligence, we leverage top trademark trends, insights and developments to unlock fast, keen solutions to clients like you. It covers numerous syndicated and customized reports using robust methodology.
Our research database features countless statistics and detailed analyses across over 6,300 reports across more than 40 domains creating business solutions for over 200 businesses in over 50 countries. Meet the key business research needs that will impact the growth trajectory of our vast clients.
This release has been published on OpenPR.
